3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitors of telomerase
AssigneeNorthwestern University
InventorsKarl A. Scheidt, Rick C. Betori
Life of this patent
Estimating the term…
Abstract
Disclosed are 3-methylideneoxan-4-one compounds, derivatives thereof, and methods of their synthesis and methods of their use in treating a disease or disorder in a subject in need thereof, such as diseases and disorders that are associated with telomerase activity such as cancer. The disclosed compounds may be formulated in a pharmaceutical composition for treating diseases and disorders that are associated with telomerase activity such as cancer.
Claims4
A method of treating cancer associated with telomerase activity in a subject in need of treatment, the method comprising administering to the subject a composition comprising an effective amount of a compound having a formula selected from the group consisting of:
- or a salt or hydrate thereof, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.